Q4 2018 EPS Estimates for LHC Group, Inc. Reduced by Analyst (LHCG)

LHC Group, Inc. (NASDAQ:LHCG) – Jefferies Financial Group lowered their Q4 2018 EPS estimates for shares of LHC Group in a research note issued on Thursday, November 1st. Jefferies Financial Group analyst B. Tanquilut now expects that the health services provider will earn $1.01 per share for the quarter, down from their prior estimate of $1.16. Jefferies Financial Group has a “Buy” rating and a $120.00 price objective on the stock.

A number of other research firms have also weighed in on LHCG. SunTrust Banks upped their target price on LHC Group to $115.00 and gave the stock a “buy” rating in a report on Thursday, September 13th. BidaskClub lowered LHC Group from a “buy” rating to a “hold” rating in a report on Wednesday, July 18th. Royal Bank of Canada upped their price target on LHC Group to $101.00 and gave the stock a “sector perform” rating in a research report on Friday, August 3rd. Benchmark set a $110.00 price target on LHC Group and gave the stock a “buy” rating in a research report on Thursday, August 2nd. Finally, Zacks Investment Research downgraded LHC Group from a “buy” rating to a “hold” rating in a research report on Wednesday. Four equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. LHC Group presently has a consensus rating of “Buy” and an average target price of $105.64.

LHC Group stock opened at $95.24 on Monday. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.17. The firm has a market cap of $2.98 billion, a price-to-earnings ratio of 39.36, a P/E/G ratio of 1.60 and a beta of 0.80. LHC Group has a twelve month low of $58.65 and a twelve month high of $103.79.

LHC Group (NASDAQ:LHCG) last posted its earnings results on Wednesday, October 31st. The health services provider reported $0.95 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.95. The company had revenue of $507.00 million during the quarter, compared to analyst estimates of $515.03 million. LHC Group had a return on equity of 8.23% and a net margin of 3.85%. LHC Group’s revenue was up 88.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.64 earnings per share.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. GW&K Investment Management LLC acquired a new position in shares of LHC Group in the 3rd quarter valued at $24,836,000. Lisanti Capital Growth LLC increased its position in shares of LHC Group by 75.0% in the 3rd quarter. Lisanti Capital Growth LLC now owns 54,005 shares of the health services provider’s stock valued at $5,562,000 after acquiring an additional 23,141 shares during the period. Janney Montgomery Scott LLC acquired a new position in shares of LHC Group in the 3rd quarter valued at $259,000. Icon Advisers Inc. Co. acquired a new position in shares of LHC Group in the 3rd quarter valued at $566,000. Finally, First National Bank of Omaha increased its position in shares of LHC Group by 243.1% in the 3rd quarter. First National Bank of Omaha now owns 69,739 shares of the health services provider’s stock valued at $7,182,000 after acquiring an additional 49,413 shares during the period. 86.50% of the stock is currently owned by hedge funds and other institutional investors.

In other news, CEO Keith G. Myers sold 75,000 shares of the company’s stock in a transaction on Tuesday, November 6th. The stock was sold at an average price of $95.10, for a total transaction of $7,132,500.00. Following the transaction, the chief executive officer now directly owns 200,765 shares of the company’s stock, valued at $19,092,751.50. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Jeff Reibel sold 1,921 shares of the company’s stock in a transaction on Monday, August 20th. The stock was sold at an average price of $94.12, for a total value of $180,804.52. Following the transaction, the senior vice president now directly owns 8,125 shares in the company, valued at $764,725. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 79,677 shares of company stock worth $7,587,030. Insiders own 6.80% of the company’s stock.

About LHC Group

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

Further Reading: Cost of Debt

Earnings History and Estimates for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply